MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression (Q38701227)

5 September 2017

title

MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression (English)

1 reference

5 September 2017

Deying Yang

1 reference

5 September 2017

Deqin Zhao

series ordinal

1 reference

5 September 2017

Xinrui Chen

series ordinal

1 reference

5 September 2017

publication date

19 May 2017

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

page(s)

425-436

1 reference

5 September 2017

cites work

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Global burden of gastric cancer attributable to Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Treatment of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Transcription factors and microRNA-co-regulated genes in gastric cancer invasion in ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

miR-935 promotes gastric cancer cell proliferation by targeting SOX7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Revised genomic organization of FBN1 and significance for regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Transcriptional profiling of the human fibrillin/LTBP gene family, key regulators of mesenchymal cell functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

miR-29b participates in early aneurysm development in Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Wnt signaling in disease and in development

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Personal health practices, health status, and expected control over future health

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Wnt signaling and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

WNT signalling pathways as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

MicroRNAs as promising biomarkers for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

Hereditary Diffuse Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160421

RETRACTED ARTICLE: Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1007/S13277-015-3918-9

Identifiers

DOI

10.3233/CBM-160421

1 reference

5 September 2017

1 reference